T. Jewell

Preparation of immobilized swainsonine analogs on solid support

W. H. Pearson, Luyi Guo, T. Jewell, 2002 .

Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor.

Hui Li, Xiu Yu, M. Hickey, 2009, Journal of medicinal chemistry.

Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors.

Hui Li, M. Hickey, P. Dragovich, 2006, Bioorganic & medicinal chemistry letters.

Optimization of potent, selective, and orally bioavailable pyrrolodinopyrimidine-containing inhibitors of heat shock protein 90. Identification of development candidate 2-amino-4-{4-chloro-2-[2-(4-fluoro-1H-pyrazol-1-yl)ethoxy]-6-methylphenyl}-N-(2,2-difluoropropyl)-5,7-dihydro-6H-pyrrolo[3,4-d]pyri

K. Gajiwala, M. Hickey, P. Kung, 2011, Journal of medicinal chemistry.